Financhill
Sell
36

ATEX Quote, Financials, Valuation and Earnings

Last price:
$30.96
Seasonality move :
6.32%
Day range:
$30.46 - $31.73
52-week range:
$29.12 - $42.41
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
103.37x
P/B ratio:
4.17x
Volume:
85.7K
Avg. volume:
123.1K
1-year change:
-8.76%
Market cap:
$579.6M
Revenue:
$4.2M
EPS (TTM):
-$2.02
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $1.6M $921K $1.1M $1.9M $4.2M
Revenue Growth (YoY) -75.94% -41.11% 17.7% 77.03% 118.4%
 
Cost of Revenues $2.8M $1.6M $5K -- --
Gross Profit -$1.3M -$685K $1.1M -- --
Gross Profit Margin -81.14% -74.38% 99.54% -- --
 
R&D Expenses $3M $4.3M $3.6M $4.4M $5.7M
Selling, General & Admin $29.5M $42.2M $44M $50.9M $50.1M
Other Inc / (Exp) $291K -$3.6M $11.4M $38.7M $42.6M
Operating Expenses $36.1M $50.1M $49M $56.8M $56.7M
Operating Income -$37.3M -$50.8M -$48M -$54.9M -$52.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$35.2M -$54.3M -$36.5M -$15.1M -$7.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.4M $124K $983K $1.3M $1.6M
Net Income to Company -$37.6M -$54.4M -$37.5M -$16.3M -$9.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$37.6M -$54.4M -$37.5M -$16.3M -$9.1M
 
Basic EPS (Cont. Ops) -$2.29 -$3.13 -$2.07 -$0.87 -$0.49
Diluted EPS (Cont. Ops) -$2.29 -$3.13 -$2.07 -$0.87 -$0.49
Weighted Average Basic Share $16.4M $17.4M $18.1M $18.8M $18.8M
Weighted Average Diluted Share $16.4M $17.4M $18.1M $18.8M $18.8M
 
EBITDA -$33.7M -$47.3M -$46.5M -$53.4M -$51.6M
EBIT -$37.3M -$50.8M -$48M -$54.9M -$52.5M
 
Revenue (Reported) $1.6M $921K $1.1M $1.9M $4.2M
Operating Income (Reported) -$37.3M -$50.8M -$48M -$54.9M -$52.5M
Operating Income (Adjusted) -$37.3M -$50.8M -$48M -$54.9M -$52.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $248K $182K $398K $1.1M $1.6M
Revenue Growth (YoY) -41.37% -26.61% 118.68% 164.32% 47.43%
 
Cost of Revenues $515K -- -- -- --
Gross Profit -$267K -- -- -- --
Gross Profit Margin -107.66% -- -- -- --
 
R&D Expenses $988K $930K $980K $1.1M $1.8M
Selling, General & Admin $14.6M $10.8M $12.6M $13.2M $12.8M
Other Inc / (Exp) $927K $10.3M $2.9M $15.8M $9K
Operating Expenses $16.8M $12.1M $13.9M $14.6M $14.7M
Operating Income -$17.1M -$11.9M -$13.5M -$13.5M -$13.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$16.1M -$1.6M -$10.4M $2.7M -$12.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $145K $152K $215K $645K $230K
Net Income to Company -$16.3M -$1.8M -$10.6M $2.1M -$12.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$16.3M -$1.8M -$10.6M $2.1M -$12.8M
 
Basic EPS (Cont. Ops) -$0.94 -$0.10 -$0.56 $0.11 -$0.69
Diluted EPS (Cont. Ops) -$0.94 -$0.10 -$0.56 $0.11 -$0.69
Weighted Average Basic Share $17.4M $17.9M $19M $18.9M $18.6M
Weighted Average Diluted Share $17.4M $17.9M $19M $19.1M $18.6M
 
EBITDA -$15.9M -$11.6M -$13.2M -$13.3M -$13M
EBIT -$17.1M -$11.9M -$13.5M -$13.5M -$13.1M
 
Revenue (Reported) $248K $182K $398K $1.1M $1.6M
Operating Income (Reported) -$17.1M -$11.9M -$13.5M -$13.5M -$13.1M
Operating Income (Adjusted) -$17.1M -$11.9M -$13.5M -$13.5M -$13.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.2M $781K $1.5M $2.8M $5.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.3M -- -- -- --
Gross Profit -$1.1M -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $3.5M $4.5M $3.7M $4.6M $7M
Selling, General & Admin $38.1M $40.9M $47.6M $51.9M $51.4M
Other Inc / (Exp) -$3.4M $10.3M $4.6M $61.8M $15.9M
Operating Expenses $46.3M $47.2M $52.8M $57.6M $59.1M
Operating Income -$47.4M -$47M -$51.4M -$54.8M -$53.5M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$49.9M -$36.5M -$46.5M $8.7M -$34.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.1M $266K $1.1M $1.3M $2.7M
Net Income to Company -$52M -$36.8M -$47.6M $7.5M -$37.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$52M -$36.8M -$47.6M $7.5M -$37.4M
 
Basic EPS (Cont. Ops) -$3.03 -$2.09 -$2.56 $0.40 -$2.02
Diluted EPS (Cont. Ops) -$3.03 -$2.09 -$2.56 $0.40 -$2.02
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$42.6M -$45.2M -$49.9M -$53.6M -$52.8M
EBIT -$47.4M -$47M -$51.4M -$54.8M -$53.5M
 
Revenue (Reported) $1.2M $781K $1.5M $2.8M $5.6M
Operating Income (Reported) -$47.4M -$47M -$51.4M -$54.8M -$53.5M
Operating Income (Adjusted) -$47.4M -$47M -$51.4M -$54.8M -$53.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $504K $364K $733K $1.7M $3.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.1M -- -- -- --
Gross Profit -$559K -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.8M $1.9M $2.1M $2.2M $3.5M
Selling, General & Admin $22.9M $21.6M $25.2M $26.2M $27.5M
Other Inc / (Exp) -$3.7M $10.3M $3.6M $26.8M $118K
Operating Expenses $27.1M $24.2M $28M $28.8M $31.3M
Operating Income -$27.6M -$23.8M -$27.3M -$27.2M -$28.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$31.3M -$13.5M -$23.4M $360K -$26.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $156K $298K $415K $405K $1.5M
Net Income to Company -$31.4M -$13.8M -$23.8M -$45K -$28.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$31.4M -$13.8M -$23.8M -$45K -$28.3M
 
Basic EPS (Cont. Ops) -$1.82 -$0.78 -$1.27 -- -$1.53
Diluted EPS (Cont. Ops) -$1.82 -$0.78 -$1.27 -- -$1.53
Weighted Average Basic Share $34.6M $35.6M $37.6M $37.9M $37.1M
Weighted Average Diluted Share $34.6M $35.6M $37.6M $38.1M $37.1M
 
EBITDA -$25.2M -$23.2M -$26.5M -$26.7M -$27.9M
EBIT -$27.6M -$23.8M -$27.3M -$27.2M -$28.2M
 
Revenue (Reported) $504K $364K $733K $1.7M $3.1M
Operating Income (Reported) -$27.6M -$23.8M -$27.3M -$27.2M -$28.2M
Operating Income (Adjusted) -$27.6M -$23.8M -$27.3M -$27.2M -$28.2M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $137.5M $117.5M $105.6M $43.2M $60.6M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $61K $4K -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $4.6M $3.5M -- -- --
Other Current Assets -- -- $10.1M $2.4M $3.9M
Total Current Assets $142.2M $121.1M $115.8M $59.5M $73M
 
Property Plant And Equipment $13.5M $8.7M $7M $7M $6.5M
Long-Term Investments $39K -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- $122.1M $151.2M $202M $216.7M
Other Long-Term Assets $180K $1.2M $4.1M $1.2M $8.9M
Total Assets $267.4M $253.1M $278M $278.6M $324.9M
 
Accounts Payable $645K $500K $1M $755K $696K
Accrued Expenses $5M $5.8M $5.5M $5.9M $7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.7M $1.5M $1.5M $1.7M $1.9M
Other Current Liabilities -- -- -- $20.2M $1M
Total Current Liabilities $8.8M $8.6M $9.6M $31.9M $18M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $22.3M $40.5M $91.7M $98.8M $163.9M
 
Common Stock $2K $2K $2K $2K $2K
Other Common Equity Adj -- -- -- -- --
Common Equity $245.1M $212.5M $186.3M $179.8M $161M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $245.1M $212.5M $186.3M $179.8M $161M
 
Total Liabilities and Equity $267.4M $253.1M $278M $278.6M $324.9M
Cash and Short Terms $137.5M $117.5M $105.6M $43.2M $60.6M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $116.2M $100.9M $70.1M $48.5M $43.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $59K -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses $2.4M $5.5M $11.7M -- --
Other Current Assets -- -- -- $13.6M $1.6M
Total Current Assets $118.6M $106.4M $81.8M $62.1M $56.8M
 
Property Plant And Equipment $10.4M $7.6M $6.9M $5.1M $6.7M
Long-Term Investments $23K -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles $117.3M -- $159.5M $197.6M $221.9M
Other Long-Term Assets $210K $1.7M $7.8M $15M $8.1M
Total Assets $246.6M $246.5M $255.9M $279.9M $317.2M
 
Accounts Payable $4M $4.7M $5.4M $7M $7.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.5M $1.4M $1.6M $1.6M $1.8M
Other Current Liabilities -- -- $20.2M $1.4M $1M
Total Current Liabilities $6.5M $7M $29.9M $15.3M $15.8M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $19.3M $43.4M $89.8M $103.8M $178.2M
 
Common Stock $2K $2K $2K $2K $2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $227.3M $203M $166.1M $176.1M $139.1M
 
Total Liabilities and Equity $246.6M $246.5M $255.9M $279.9M $317.2M
Cash and Short Terms $116.2M $100.9M $70.1M $48.5M $43.1M
Total Debt -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -$37.6M -$54.4M -$37.5M -$16.3M -$9.1M
Depreciation & Amoritzation $3.6M $3.5M $1.5M $1.4M $844K
Stock-Based Compensation $5.8M $15.9M $13.6M $17.9M $15.5M
Change in Accounts Receivable $464K $57K $4K -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$27.8M -$10M $17.9M -$27.3M $42M
 
Capital Expenditures $7.6M $14.2M $27.4M $27.1M $17.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$7.6M -$14.2M -$27.4M -$27.1M $8.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$15M -$8.2M -$24.7M
Other Financing Activities -$566K -- -$1.5M -$1.6M -$1.2M
Cash From Financing $96.1M $4.2M -$2.4M -$8.1M -$25.1M
 
Beginning Cash (CF) $76.7M $137.5M $117.5M $105.6M $43.2M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $60.7M -$19.9M -$11.9M -$62.4M $24.9M
Ending Cash (CF) $137.5M $117.5M $105.6M $43.2M $68.1M
 
Levered Free Cash Flow -$35.4M -$24.1M -$9.5M -$54.4M $24.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$16.3M -$1.8M -$10.6M $2.1M -$12.8M
Depreciation & Amoritzation $1.2M $335K $372K $209K $151K
Stock-Based Compensation $8.6M $3.2M $4.7M $3.8M $3.4M
Change in Accounts Receivable -$34K -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$7.4M -$2.9M -$8.1M $10.4M -$2.6M
 
Capital Expenditures $1.7M $5.7M $5.7M $5.1M $5.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$1.7M -$5.7M -$5.7M $20.1M -$5.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$2M -$10.7M --
Other Financing Activities -- -$1.3M -$509K -$270K -$705K
Cash From Financing $513K $2.6M -$2.5M -$11M -$362K
 
Beginning Cash (CF) $124.8M $106.9M $86.5M $29M $59.3M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$8.6M -$6M -$16.3M $19.5M -$8.6M
Ending Cash (CF) $116.2M $100.9M $70.1M $48.5M $50.7M
 
Levered Free Cash Flow -$9.1M -$8.7M -$13.8M $5.3M -$8.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$52M -$36.8M -$47.6M $7.5M -$37.4M
Depreciation & Amoritzation $4.7M $1.8M $1.5M $1.1M $719K
Stock-Based Compensation $13.4M $11.9M $15.9M $17.2M $15.2M
Change in Accounts Receivable $85K $59K -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$28M -$7.8M $12.6M -$7.1M $34.8M
 
Capital Expenditures $15.1M $18.2M $27.7M $25M $18M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$15.1M -$18.2M -$27.7M $132K -$17.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$19.7M -$14.2M -$16M
Other Financing Activities -- -- -$1.5M -$1.3M -$1.6M
Cash From Financing $1.8M $10.7M -$15.6M -$14.6M -$14.8M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$41.3M -$15.3M -$30.8M -$21.6M $2.2M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$43.1M -$26M -$15.2M -$32.1M $16.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$31.4M -$13.8M -$23.8M -$45K -$28.3M
Depreciation & Amoritzation $2.4M $673K $734K $455K $330K
Stock-Based Compensation $10.6M $6.5M $8.8M $8.1M $7.8M
Change in Accounts Receivable $2K $4K -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -$14.7M -$12.6M -$17.9M $2.2M -$5M
 
Capital Expenditures $8M $12.1M $12.4M $10.3M $10.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8M -$12.1M -$12.4M $14.9M -$10.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$4.7M -$10.7M -$2M
Other Financing Activities -- -$1.3M -$1.3M -$1M -$1.4M
Cash From Financing $1.5M $8M -$5.2M -$11.8M -$1.4M
 
Beginning Cash (CF) $262.2M $224.4M $192.1M $72.2M $127.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$21.2M -$16.7M -$35.5M $5.4M -$17.4M
Ending Cash (CF) $241M $207.8M $156.6M $77.6M $110M
 
Levered Free Cash Flow -$22.8M -$24.7M -$30.3M -$8.1M -$16M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 6.38% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is up 0.85% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is down 0.46% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock